BIOMAT Database Logo BIOMAT Database Logo

Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment. 2013

Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine , Itabashi, Tokyo , Japan.

We report the first case of primary central nervous system lymphoma (PCNSL) developing in a patient with rheumatoid arthritis (RA) undergoing low-dose methotrexate therapy (LD-MTX). The characteristic clinical management and course in our experience of the present case illustrate the important points about PCNSL in methotrexate-associated lymphoproliferative disorders (MTX-LPD). The number of cases of MTX-LPD in RA patients may increase in the future, since current treatment strategies for RA recommend starting MTX use in early stage RA, and recent insights have tended to show an increase with higher doses.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D016543 Central Nervous System Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges. CNS Neoplasm,CNS Neoplasms,Central Nervous System Neoplasm,Central Nervous System Tumor,Neoplasms, Central Nervous System,Primary Central Nervous System Neoplasm,Central Nervous System Neoplasms, Primary,Central Nervous System Tumors,Primary Central Nervous System Neoplasms,Tumors, Central Nervous System,Neoplasm, CNS,Neoplasms, CNS

Related Publications

Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab: illustrative case.
August 2022, Journal of neurosurgery. Case lessons,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report.
March 2015, BMC research notes,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
[Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
August 2018, Rinsho shinkeigaku = Clinical neurology,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Primary central nervous system lymphoma in rheumatoid arthritis.
February 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
High-dose methotrexate and primary central nervous system lymphoma.
April 2007, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Rituximab with high-dose methotrexate in primary central nervous system lymphoma.
December 2015, American journal of hematology,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
September 2001, Annals of the rheumatic diseases,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate.
April 1980, Cancer,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate.
November 1991, The Journal of rheumatology,
Masamichi Fukushima, and Yoichi Katayama, and Noriaki Yokose, and Yoshimasa Kura, and Umihiko Sawada, and Akio Kotani, and Atsuo Yoshino
Cirrhosis in patients with rheumatoid arthritis receiving low dose methotrexate.
October 1994, British journal of rheumatology,
Copied contents to your clipboard!